Logo image of BXC

BLUELINX HOLDINGS INC (BXC) Stock Fundamental Analysis

NYSE:BXC - US09624H2085 - Common Stock

82.39 USD
-1.25 (-1.49%)
Last: 8/27/2025, 1:39:44 PM
Fundamental Rating

4

Taking everything into account, BXC scores 4 out of 10 in our fundamental rating. BXC was compared to 48 industry peers in the Trading Companies & Distributors industry. BXC has only an average score on both its financial health and profitability. BXC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

BXC had positive earnings in the past year.
In the past year BXC had a positive cash flow from operations.
In the past 5 years BXC has always been profitable.
BXC had a positive operating cash flow in each of the past 5 years.
BXC Yearly Net Income VS EBIT VS OCF VS FCFBXC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

1.2 Ratios

The Return On Assets of BXC (1.79%) is worse than 64.58% of its industry peers.
BXC has a worse Return On Equity (4.57%) than 64.58% of its industry peers.
BXC has a worse Return On Invested Capital (3.08%) than 72.92% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BXC is in line with the industry average of 9.70%.
The last Return On Invested Capital (3.08%) for BXC is well below the 3 year average (11.49%), which needs to be investigated, but indicates that BXC had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.79%
ROE 4.57%
ROIC 3.08%
ROA(3y)8.8%
ROA(5y)11.32%
ROE(3y)22.02%
ROE(5y)56.9%
ROIC(3y)11.49%
ROIC(5y)14.44%
BXC Yearly ROA, ROE, ROICBXC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

BXC has a Profit Margin of 0.96%. This is in the lower half of the industry: BXC underperforms 64.58% of its industry peers.
In the last couple of years the Profit Margin of BXC has declined.
BXC's Operating Margin of 2.09% is on the low side compared to the rest of the industry. BXC is outperformed by 72.92% of its industry peers.
In the last couple of years the Operating Margin of BXC has grown nicely.
With a Gross Margin value of 15.94%, BXC is not doing good in the industry: 89.58% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of BXC has grown nicely.
Industry RankSector Rank
OM 2.09%
PM (TTM) 0.96%
GM 15.94%
OM growth 3Y-33.48%
OM growth 5Y28.68%
PM growth 3Y-36.19%
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y4.13%
BXC Yearly Profit, Operating, Gross MarginsBXC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

More info and screens

6

2. Health

2.1 Basic Checks

BXC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for BXC has been reduced compared to 1 year ago.
Compared to 5 years ago, BXC has less shares outstanding
BXC has a better debt/assets ratio than last year.
BXC Yearly Shares OutstandingBXC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
BXC Yearly Total Debt VS Total AssetsBXC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 3.52 indicates that BXC is not in any danger for bankruptcy at the moment.
BXC has a Altman-Z score of 3.52. This is comparable to the rest of the industry: BXC outperforms 54.17% of its industry peers.
A Debt/Equity ratio of 0.96 indicates that BXC is somewhat dependend on debt financing.
The Debt to Equity ratio of BXC (0.96) is worse than 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF N/A
Altman-Z 3.52
ROIC/WACC0.33
WACC9.27%
BXC Yearly LT Debt VS Equity VS FCFBXC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 4.55 indicates that BXC has no problem at all paying its short term obligations.
With an excellent Current ratio value of 4.55, BXC belongs to the best of the industry, outperforming 93.75% of the companies in the same industry.
A Quick Ratio of 2.94 indicates that BXC has no problem at all paying its short term obligations.
BXC has a better Quick ratio (2.94) than 95.83% of its industry peers.
Industry RankSector Rank
Current Ratio 4.55
Quick Ratio 2.94
BXC Yearly Current Assets VS Current LiabilitesBXC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for BXC have decreased strongly by -63.76% in the last year.
BXC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -40.26% yearly.
The Revenue has decreased by -2.32% in the past year.
BXC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.28% yearly.
EPS 1Y (TTM)-63.76%
EPS 3Y-40.26%
EPS 5YN/A
EPS Q2Q%-58.33%
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-11.62%
Revenue growth 5Y2.28%
Sales Q2Q%1.53%

3.2 Future

BXC is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -24.98% yearly.
BXC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.90% yearly.
EPS Next Y-76.57%
EPS Next 2Y-24.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.35%
Revenue Next 2Y2.9%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BXC Yearly Revenue VS EstimatesBXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B
BXC Yearly EPS VS EstimatesBXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2019 2020 2021 2022 2023 2024 2025 2026 0 10 20 30

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 23.34, which indicates a rather expensive current valuation of BXC.
BXC's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.08, BXC is valued at the same level.
Based on the Price/Forward Earnings ratio of 22.95, the valuation of BXC can be described as rather expensive.
62.50% of the companies in the same industry are cheaper than BXC, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.67. BXC is around the same levels.
Industry RankSector Rank
PE 23.34
Fwd PE 22.95
BXC Price Earnings VS Forward Price EarningsBXC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

BXC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BXC is cheaper than 77.08% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.92
BXC Per share dataBXC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200 300

4.3 Compensation for Growth

A cheap valuation may be justified as BXC's earnings are expected to decrease with -24.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-24.98%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BXC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BLUELINX HOLDINGS INC

NYSE:BXC (8/27/2025, 1:39:44 PM)

82.39

-1.25 (-1.49%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)07-29 2025-07-29/amc
Earnings (Next)10-27 2025-10-27/amc
Inst Owners95.61%
Inst Owner Change-4.96%
Ins Owners2.21%
Ins Owner Change0.56%
Market Cap650.06M
Analysts77.5
Price Target83.64 (1.52%)
Short Float %5.82%
Short Ratio3.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-11.89%
Min EPS beat(2)-24.67%
Max EPS beat(2)0.88%
EPS beat(4)3
Avg EPS beat(4)13.48%
Min EPS beat(4)-24.67%
Max EPS beat(4)61.56%
EPS beat(8)6
Avg EPS beat(8)23.04%
EPS beat(12)8
Avg EPS beat(12)14.37%
EPS beat(16)12
Avg EPS beat(16)22.17%
Revenue beat(2)0
Avg Revenue beat(2)-1.43%
Min Revenue beat(2)-1.64%
Max Revenue beat(2)-1.23%
Revenue beat(4)1
Avg Revenue beat(4)-1.24%
Min Revenue beat(4)-2.52%
Max Revenue beat(4)0.42%
Revenue beat(8)2
Avg Revenue beat(8)-2.07%
Revenue beat(12)2
Avg Revenue beat(12)-3.74%
Revenue beat(16)6
Avg Revenue beat(16)-0.03%
PT rev (1m)-10.14%
PT rev (3m)-10.14%
EPS NQ rev (1m)-48.49%
EPS NQ rev (3m)-58.37%
EPS NY rev (1m)-51.91%
EPS NY rev (3m)-51.91%
Revenue NQ rev (1m)-1.74%
Revenue NQ rev (3m)-4.12%
Revenue NY rev (1m)-1.34%
Revenue NY rev (3m)-1.34%
Valuation
Industry RankSector Rank
PE 23.34
Fwd PE 22.95
P/S 0.22
P/FCF N/A
P/OCF 32.76
P/B 1.05
P/tB 1.2
EV/EBITDA 8.92
EPS(TTM)3.53
EY4.28%
EPS(NY)3.59
Fwd EY4.36%
FCF(TTM)-3.02
FCFYN/A
OCF(TTM)2.51
OCFY3.05%
SpS373.54
BVpS78.75
TBVpS68.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.79%
ROE 4.57%
ROCE 4.59%
ROIC 3.08%
ROICexc 4.33%
ROICexgc 4.73%
OM 2.09%
PM (TTM) 0.96%
GM 15.94%
FCFM N/A
ROA(3y)8.8%
ROA(5y)11.32%
ROE(3y)22.02%
ROE(5y)56.9%
ROIC(3y)11.49%
ROIC(5y)14.44%
ROICexc(3y)16.25%
ROICexc(5y)17.76%
ROICexgc(3y)18%
ROICexgc(5y)19.38%
ROCE(3y)17.1%
ROCE(5y)21.48%
ROICexcg growth 3Y-37.08%
ROICexcg growth 5Y30.14%
ROICexc growth 3Y-37.9%
ROICexc growth 5Y30.02%
OM growth 3Y-33.48%
OM growth 5Y28.68%
PM growth 3Y-36.19%
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y4.13%
F-Score3
Asset Turnover1.86
Health
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF N/A
Debt/EBITDA 6
Cap/Depr 115.37%
Cap/Sales 1.48%
Interest Coverage 1.33
Cash Conversion 19.97%
Profit Quality N/A
Current Ratio 4.55
Quick Ratio 2.94
Altman-Z 3.52
F-Score3
WACC9.27%
ROIC/WACC0.33
Cap/Depr(3y)106.72%
Cap/Depr(5y)76.81%
Cap/Sales(3y)1.01%
Cap/Sales(5y)0.7%
Profit Quality(3y)260.74%
Profit Quality(5y)177.95%
High Growth Momentum
Growth
EPS 1Y (TTM)-63.76%
EPS 3Y-40.26%
EPS 5YN/A
EPS Q2Q%-58.33%
EPS Next Y-76.57%
EPS Next 2Y-24.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.32%
Revenue growth 3Y-11.62%
Revenue growth 5Y2.28%
Sales Q2Q%1.53%
Revenue Next Year1.35%
Revenue Next 2Y2.9%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-48.23%
EBIT growth 3Y-41.21%
EBIT growth 5Y31.62%
EBIT Next Year-5.4%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-105.85%
FCF growth 3Y-29.86%
FCF growth 5YN/A
OCF growth 1Y-95.59%
OCF growth 3Y-16.25%
OCF growth 5YN/A